13th EGA European Biosimilars Group Conference – 23 April 2015 – Video Playlist

For information on the 14th gathering of the world’s Biosimilars experts on 28-29 April 2016, go to: http://www.egaevents.org/bios/

 

Sabine Juelicher – Welcome and Keynote Address (1/2):

Sabine Juelicher – Welcome and Keynote Address (2/2):

Nick Haggar – Opening Keynote Speech (1/2):

Nick Haggar – Opening Keynote Speech (2/2):

Martina Weise – The science of extrapolation (1/2):

Martina Weise – The science of extrapolation (2/2):

Considerations on WHO’s BQ Proposal – Joerg Windisch, 60th INN Consultation WHO, Geneva, 13 April 2015 (PPT)

Sans-titre-4

EMA Information Session on Biosimilars for Patients and Healthcare Professionals

 

What you Need to Know About Biosimilar Medicinal Products

European Commission Consensus Information Document: What you Need to Know About Biosimilar Medicinal Products.

To view the full report, please click here.

French Parliament Public Hearing on Biosimilar Medicines, Paris, 29 January 2015 – Intervention from EMA Spokesperson Camille Vleminckx

French_Parliament_Public_Hearing_on_Biosimilar_Medicines_1

Labelling & Naming – EBG Perspective, DIA Berlin 2014

Sans-titre-4

WHO BQ Proposal – EGA’s perspective, 59th INN Consultation, WHO, Geneva, 14 October 2014

Sans-titre-4

GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

A study about the future sustainability of the biosimilar medicines market undertaken by GfK Market Access on behalf of the European Biosimilars Group, now the Biosimilar Medicines Group.

picto-full             picto-infographic   picto-project

 

 

EMA mAb Workshop – Guideline on Similar Biological Medicinal Products

EMA mAb Workshop – Quality Target Product Profile in the Development of a Biosimilar

Medicines For Europe